propranolol has been researched along with Dermatitis, Atopic in 9 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed." | 3.79 | What's new in pediatric dermatology?: part II. Treatment. ( Pride, HB; Silverman, R; Tollefson, M, 2013) |
| " Oral propranolol is currently the first choice in the treatment of alarming infantile hemangiomas." | 3.76 | Innovative therapeutics in pediatric dermatology. ( Frasin, A; Gelmetti, C; Restano, L, 2010) |
| "Quantitative measurements of eccrine sweat secretion following stimulation with adrenaline and terbutaline sulphate, a beta-stimulator, have been performed in patients with atopic dermatitis and psoriasis by means of the electrolytic water analyzer, "Meeco"." | 3.65 | Effects of adrenergic stimulating and blocking agents on the eccrine sweat secretion in atopic dermatitis and psoriasis. ( Kocsis, M; Thune, P, 1975) |
| "Congenital or atypical nevi of the child benefit from genetic progress or improvement of clinical knowledge." | 2.49 | [What’s new in pediatric dermatology?]. ( Lacour, JP, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pride, HB | 1 |
| Tollefson, M | 1 |
| Silverman, R | 1 |
| Lacour, JP | 1 |
| Gelmetti, C | 1 |
| Frasin, A | 1 |
| Restano, L | 1 |
| Delgado, M | 1 |
| Fernández-Alfonso, MS | 1 |
| Fuentes, A | 1 |
| Danilov, LN | 1 |
| Hovmark, A | 1 |
| Asbrink, E | 1 |
| Kramár, J | 1 |
| Thune, P | 1 |
| Kocsis, M | 1 |
| Hemels, HG | 1 |
2 reviews available for propranolol and Dermatitis, Atopic
| Article | Year |
|---|---|
[What’s new in pediatric dermatology?].
Topics: Adolescent; Child; Dermatitis, Atopic; Dermatology; Hemangioma, Capillary; Humans; Melanoma; Neoplas | 2013 |
The effect of propranolol on the acetylcholine-induced sweat gland response in atopic and non-atopic subjects.
Topics: Acetylcholine; Dermatitis, Atopic; Humans; Injections, Intradermal; Models, Biological; Propranolol; | 1970 |
7 other studies available for propranolol and Dermatitis, Atopic
| Article | Year |
|---|---|
What's new in pediatric dermatology?: part II. Treatment.
Topics: Acyclovir; Antiviral Agents; Dermatitis, Atopic; Dermatology; Hemangioma; Humans; Internet; Proprano | 2013 |
Innovative therapeutics in pediatric dermatology.
Topics: Adolescent; Adrenal Cortex Hormones; Alopecia Areata; Autoimmune Diseases; Child; Child, Preschool; | 2010 |
Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Atenolol; Colforsin; Cy | 2002 |
[Toxicodermia from using the beta-adrenoblockader, trazicor].
Topics: Adrenergic beta-Antagonists; Dermatitis, Atopic; Drug Hypersensitivity; Female; Humans; Hypersensiti | 1981 |
Effects of a beta-receptor blocking agent (propranolol) on synthesis of IgE in vitro by peripheral blood lymphocytes from atopic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Cells, Cultured; Dermatitis, Atopic; Desensitization, Immunolog | 1981 |
Pharmacodynamic study of the capillaries of normal and allergic (atopic) subjects.
Topics: Adolescent; Adult; Animals; Asthma; Capillary Resistance; Catecholamines; Child; Cyclic AMP; Dermati | 1975 |
Effects of adrenergic stimulating and blocking agents on the eccrine sweat secretion in atopic dermatitis and psoriasis.
Topics: Adrenergic Agonists; Atropine; Dermatitis, Atopic; Eccrine Glands; Epinephrine; Humans; Isoprotereno | 1975 |